IL17A and psoriasis: To enhance the reliability of this study on abnormal LCFA metabolism in psoriasis patients, not only were the differences in LCFA metabolism between healthy individuals and psoriasis patients were compared, but also the metabolic changes in LCFAs in each psoriasis patient before and after anti-IL-17A mAb treatment were investigated.